Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis : APLIOS, a randomized phase-2 study
author
Bar-Or, Amit
Wiendl, Heinz
Montalban, Xavier
Alvarez, Enrique
Davydovskaya, Maria
Delgado, Silvia R.
Evdoshenko, Evgeniy
Giedraitiene, Natasa
Haldre, Sulev
statement of authorship
Amit Bar-Or, Heinz Wiendl, Xavier Montalban, Enrique Alvarez, Maria Davydovskaya, Silvia R Delgado, Evgeniy P Evdoshenko, Natasa Giedraitiene, Katrin Gross-Paju, Sulev Haldre, Craig E Herrman, Guillermo Izquierdo, Guntis Karelis, Fritz Leutmezer, Miroslav Mares, Jose E Meca-Lallana, Dalia Mickeviciene, Jacqueline Nicholas, Derrick S Robertson, Denis V Sazonov, Kenneth Sharlin, Bharathy Sundaram, Natalia Totolyan, Marta Vachova, Martin Valis, Morten Bagger, Dieter A Häring, Inga Ludwig, Roman Willi, Martin Zalesak, Wendy Su, Martin Merschhemke, Edward J Fox, and on behalf of the APLIOS trial investigators
source
Multiple Sclerosis Journal
publisher
journal volume number month
vol. 28, 6
year of publication
pages
p. 849-1002
ISSN
1477-0970
1352-4585
notes
Bibliogr.: 27 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
language
inglise
subject term
keyword
classifier
kvartiil
category (general)
category (sub)
TTÜ department
Bar-Or, A., Wiendl, H., Montalban, X., Alvarez, E., Davydovskaya, M., Delgado, S. R., Evdoshenko, E. P., Giedraitiene, N., Gross-Paju, K., Haldre, S. et al. Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis : APLIOS, a randomized phase-2 study // Multiple Sclerosis Journal (2022) vol. 28, 6, p. 849-1002.